Navigation Links
FDA debates status of decongestant drugs

An advisory committee for the Food and Drug Administration agreed that an ingredient commonly used in over-the-counter decongestants is unsafe, and it plans to recommend further review by the FDA.

The FDA Non-Prescription Drugs Advisory Committee met to discuss a new five-year study by Yale University researchers that found phenyl-propanolamine (PPA), an active ingredient in non-prescription drugs, can increase the risk of stroke in some users. PPA helps constrict blood vessels, thus relieving nasal congestion, and has been shown to aid in weight loss.// The compound is in hundreds of over-the-counter cold, cough and allergy medicines and appetite suppressants.

And while products containing such ingredients are required to list such warnings on their labels, the warnings often go unnoticed or ignored by many who assume over-the-counter drugs are safe for one and all. One big reason such warnings may be ignored is because nearly half of the estimated 50 million people in the United States with high blood pressure don't even realize they have a problem.

The problem is that the active ingredients in many decongestants can't target the blood vessels in the nose. Instead, they constrict blood vessels throughout your body, and raise your blood pressure. If you already have high blood pressure, that can increase your risk for stroke or heart attack.

Furthermore, the decongestants can work against anti-hypertensive drugs that patients might take for their high blood pressure. There are over-the-counter cold and flu products that claim to be safe for people with high blood pressure, but they're unlikely to help those looking for a decongestant.
'"/>




Page: 1

Related medicine news :

1. Patient’s perception of health status helps in better recover
2. Jharkhand Gives Health industry status
3. Gay and HIV + men have no qualms revealing HIV status
4. Specialist status for breast doctors may be revoked
5. The connection between socioeconomic status and risk of stroke
6. Cancer drugs in development nearly doubled since 1995
7. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
8. African HIV strains more resistant to anti HIV drugs
9. Right drugs drastically cut stroke risk
10. Relating heart protection and antihypertensive drugs
11. Enzyme may be target for obesity drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... , ... In sleep, when the defenses of the day are at rest, ... with eating disorders is significant self-criticism, and consequently these patients experience this disease with ... maladaptive means for coping with this unease, but also leads to a reservoir of ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... practical mobile kitchens, recently announced the debut of their latest mobile kitchen model, ... Kitchens provides organizations with modern, high-volume commercial kitchens for use anywhere in the ...
(Date:2/5/2016)... Moscow, Russia (PRWEB) , ... February 05, 2016 , ... ... update has a completely new user interface design and the developer has fixed known ... with those they want to on their phone while not consuming any of their ...
(Date:2/5/2016)... ... , ... –This week, Atascadero water heater company First Call Plumbing ... view the report, click here or see below. , There are ... and cons, the type chosen is almost entirely up to personal preference. However, tankless ...
(Date:2/5/2016)... ... ... tired of trying to cram belongings into spare space that just isn’t there, a self-storage ... before hastily spending money on a unit, take these tips into consideration. , Self-storage is ... often not told when utilizing these services are some tips on how to use the ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... For hospitals considering enrollment in the Federal ... the program, the Health Resources and Services Administration,s (HRSA) ... Mega-Guidance , could have significant impact on plans and ... 2016. Essential Insights , Daniel Neal, ... the Mega-Guidance,s key proposed changes, including a new requirement ...
(Date:2/4/2016)... 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN ... into a settlement agreement with the United States ... SEC,s investigation into possible violations of the Foreign ... the settlement agreement, SciClone has agreed to pay ... interest and a penalty.  This payment is in ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Identifying and Commercializing First-in-Class Innovation ... disorder associated with chronic inflammation of the airways ... of COPD symptoms make the disease one of ... cause of death in the world. COPD is ...
Breaking Medicine Technology: